JP2002539804A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002539804A5 JP2002539804A5 JP2000607009A JP2000607009A JP2002539804A5 JP 2002539804 A5 JP2002539804 A5 JP 2002539804A5 JP 2000607009 A JP2000607009 A JP 2000607009A JP 2000607009 A JP2000607009 A JP 2000607009A JP 2002539804 A5 JP2002539804 A5 JP 2002539804A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally
- blood mononuclear
- proliferation
- cells
- mononuclear cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR99/03622 | 1999-03-19 | ||
| FR9903622A FR2791139B1 (fr) | 1999-03-19 | 1999-03-19 | Procede de detection d'une activite superantigenique dans un echantillon biologique |
| FR99/13755 | 1999-10-28 | ||
| FR9913755A FR2791140B1 (fr) | 1999-03-19 | 1999-10-28 | Procede de detection d'une activite superantigenique dans un echantillon et composition therapeutique ou prophylactique |
| PCT/FR2000/000691 WO2000057185A1 (fr) | 1999-03-19 | 2000-03-20 | Detection d'une activite superantigenique dans un echantillon biologique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002539804A JP2002539804A (ja) | 2002-11-26 |
| JP2002539804A5 true JP2002539804A5 (https=) | 2005-06-23 |
Family
ID=26234877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000607009A Ceased JP2002539804A (ja) | 1999-03-19 | 2000-03-20 | 生物学的サンプルにおけるスーパー抗原活性を検出する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20060088820A1 (https=) |
| EP (1) | EP1163522B1 (https=) |
| JP (1) | JP2002539804A (https=) |
| AT (1) | ATE346299T1 (https=) |
| AU (1) | AU3437700A (https=) |
| CA (1) | CA2366552A1 (https=) |
| DE (1) | DE60031963T2 (https=) |
| ES (1) | ES2276675T3 (https=) |
| FR (1) | FR2791140B1 (https=) |
| WO (1) | WO2000057185A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010148323A2 (en) * | 2009-06-18 | 2010-12-23 | Whittemore Peterson Institute For Neuro-Immune Disease | Diagnosis and treatment of diseases or disorders associated with xenotropic murine leukemia virus |
| US20110151431A1 (en) * | 2009-06-18 | 2011-06-23 | Whittemore Peterson Institute For Neuro-Immune Disease | Detection of xenotropic murine leukemia virus |
| US20110117056A1 (en) * | 2009-06-18 | 2011-05-19 | Whittemore Peterson Institute For Neuro-Immune Disease | Diagnosis and treatment of diseases or disorders associated with xenotropic murine leukemia virus |
| US20100167268A1 (en) * | 2009-07-15 | 2010-07-01 | Mikovits Judy A | Seroconversion assays for detecting xenotropic murine leukemia virus-related virus |
| EP2949342A1 (en) * | 2014-05-28 | 2015-12-02 | Geneuro SA | Antiretroviral drug targeting human endogenous retrovirus |
| US12331320B2 (en) | 2018-10-10 | 2025-06-17 | The Research Foundation For The State University Of New York | Genome edited cancer cell vaccines |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9310657D0 (en) * | 1993-05-24 | 1993-07-07 | Univ London | Retrovirus |
| WO1998026747A2 (en) * | 1996-12-17 | 1998-06-25 | Terman David S | Superantigen based methods and compositions for treatment of diseases |
| FR2765588A1 (fr) * | 1997-07-07 | 1999-01-08 | Bio Merieux | Materiel nucleique retroviral et fragments nucleotidiques notamment associes a la sclerose en plaques et/ou la polyarthrite rhumatoide, a des fins de diagnostic, prophylactiques et therapeutiques |
-
1999
- 1999-10-28 FR FR9913755A patent/FR2791140B1/fr not_active Expired - Fee Related
-
2000
- 2000-03-20 JP JP2000607009A patent/JP2002539804A/ja not_active Ceased
- 2000-03-20 EP EP00912720A patent/EP1163522B1/fr not_active Expired - Lifetime
- 2000-03-20 AT AT00912720T patent/ATE346299T1/de not_active IP Right Cessation
- 2000-03-20 ES ES00912720T patent/ES2276675T3/es not_active Expired - Lifetime
- 2000-03-20 AU AU34377/00A patent/AU3437700A/en not_active Abandoned
- 2000-03-20 WO PCT/FR2000/000691 patent/WO2000057185A1/fr not_active Ceased
- 2000-03-20 CA CA002366552A patent/CA2366552A1/fr not_active Abandoned
- 2000-03-20 DE DE60031963T patent/DE60031963T2/de not_active Expired - Lifetime
-
2005
- 2005-10-31 US US11/261,673 patent/US20060088820A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100235849B1 (ko) | HIV에 대한 면역응답을 유도할 수 있는 펩티드 및 그 펩티드를 함유하는 항 AIDS 예방, 치료제(Peptides Capable of Inducing Immune Response to HIV and Anti-AIDS Agent for Preventing and Curing AIDS) | |
| RU2138512C1 (ru) | Вакцина для профилактики или лечения опосредованной т-клетками патологии или нерегулируемой репликации клонами т-клеток, способ выделения вакцины, способ диагностирования или прогнозирования восприимчивости к ревматоидному артриту или рассеянному склерозу, способ профилактики или лечения ревматоидного артрита или рассеянного склероза и содержащий последовательность sgdqggne пептид, являющийся агентом для обнаружения, профилактики или лечения рассеянного склероза | |
| CN1072719C (zh) | 可分离的编码肿瘤排斥抗原前体的核酸序列 | |
| US7148326B2 (en) | Tumor antigen | |
| Li et al. | Cryptic epitope identified in rat and human cardiac myosin S2 region induces myocarditis in the Lewis rat | |
| CN110357953B (zh) | 识别人巨细胞病毒pp65抗原的TCR | |
| JP2006516190A5 (https=) | ||
| EP0611394A1 (en) | Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids | |
| Bettinotti et al. | Stringent allele/epitope requirements for MART-1/Melan A immunodominance: implications for peptide-based immunotherapy | |
| Kishi et al. | Resistance to fas-mediated apoptosis of peripheral T cells in human T lymphocyte virus type I (HTLV-I) transgenic mice with autoimmune arthropathy | |
| US11767352B2 (en) | Histone anti-cancer vaccines | |
| CN114302962B (zh) | 特异性针对来源于ebv抗原的tcr构建体 | |
| CN116970058B (zh) | 针对tp53基因r249s突变的肿瘤新抗原多肽及其应用 | |
| RU2398776C2 (ru) | Тимус-специфический белок | |
| Smith Jr et al. | Helicobacter pylori and toll-like receptor agonists induce syndecan-4 expression in an NF-κB-dependent manner | |
| JPH08511936A (ja) | 多発性硬化症ウィルス | |
| JP2002539804A5 (https=) | ||
| KR20060003853A (ko) | 에리트로포이에틴 내의 ｔ-세포 에피토프 | |
| KR20000016382A (ko) | Mage－b계통군의 구성원인 분리된 핵산분자 그리고 그것의사용 | |
| JP2005516586A (ja) | 癌の処置に対する遺伝子標的を同定するための試薬および方法 | |
| CN117777271A (zh) | 一种t细胞受体(tcr)及其用途 | |
| WO2017079545A1 (en) | Immunotherapy | |
| KR20060129393A (ko) | ＨＬＡ－Ａ2402-제한 Ｅｐ－ＣＡＭ 특이적 ＣＴＬ에인식되는 에피토프/펩티드 및 그 용도 | |
| US11820836B2 (en) | Polypeptide and use thereof | |
| JP2025517187A (ja) | Ｈｐｖ関連疾患を治療する薬剤のスクリーニングにおける抗原短ペプチドの使用及びそれによってスクリーニングされたｔｃｒ |